» Articles » PMID: 26771662

Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda

Overview
Specialty Pediatrics
Date 2016 Jan 16
PMID 26771662
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In high tuberculosis (TB) burden countries, a significant proportion of the latent TB reservoir is established by the age 5 years. There are critical knowledge gaps in our understanding of the age-specific prevalence of TB infection and the influence of HIV exposure on TB infection in the first 5 years of life among HIV-uninfected children in sub-Saharan Africa.

Methods: We measured TB infection with the Quantiferon Gold-in-Tube (QFT) and tuberculin skin tests (TST) in 447 children ≤60 months and their 284 HIV-infected and IV-uninfected mothers in rural Uganda.

Results: The overall prevalence of TB infection in children ≤60 months by TST was 24% (95% confidence intervals [CI]: 19.9-27.9). The prevalence of TST positivity was highest among children in their first year of life (36%; 95% CI: 26.0-45.9) and declined with age to 19% at 36-60 months of age, χ test for trend P = 0.014. In contrast, 4% (95% CI: 1.9-5.87%) of children had a positive QFT, and there was no trend detected with age, P = 0.576. QFT positivity was detected as early as 5 months. HIV-exposed uninfected children had significantly higher odds of TB infection by QFT (odds ratio [OR]: 21.2; P = 0.008; 95% CI: 2.2-204.7) or positive TST or QFT (OR, 2.4; P = 0.020; 95% CI: 1.2-5.1) compared with HIV-unexposed uninfected children, adjusting for age, BCG vaccination and a positive maternal TST or QFT.

Conclusions: An appreciable prevalence of TB infection was detected in early childhood. HIV-exposed uninfected children have a higher risk for TB infection compared with children born to HIV-uninfected mothers.

Citing Articles

Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.

Cherkos A, LaCourse S, Enquobahrie D, Escudero J, Mecha J, Matemo D PLoS One. 2024; 19(8):e0293708.

PMID: 39150949 PMC: 11329125. DOI: 10.1371/journal.pone.0293708.


Prevalence and Predictors of Tuberculosis Infection in Children and Adolescents in Rural Uganda: A Cross-sectional Study.

Kakande E, Ssekyanzi B, Abbott R, Ariho W, Nattabi G, Landsiedel K Pediatr Infect Dis J. 2024; .

PMID: 39018476 PMC: 11733060. DOI: 10.1097/INF.0000000000004475.


Community-Wide Universal HIV Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial.

Marquez C, Atukunda M, Nugent J, Charlebois E, Chamie G, Mwangwa F Clin Infect Dis. 2024; 78(6):1601-1607.

PMID: 38226445 PMC: 11175690. DOI: 10.1093/cid/ciad776.


Effect of tuberculosis-HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy.

Cherkos A, Cranmer L, Njuguna I, LaCourse S, Mugo C, Moraa H AIDS. 2023; 38(4):579-588.

PMID: 38016160 PMC: 10922257. DOI: 10.1097/QAD.0000000000003797.


Maternal HIV Status and Risk of Infant Mycobacterium tuberculosis Infection as Measured by Tuberculin Skin Test.

Mecha J, Escudero J, Richardson B, Maleche-Obimbo E, Matemo D, Kinuthia J Pediatr Infect Dis J. 2023; 43(3):250-256.

PMID: 37991383 PMC: 10922277. DOI: 10.1097/INF.0000000000004190.


References
1.
Malhotra I, Ouma J, Wamachi A, Kioko J, Mungai P, Njzovu M . Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya. Infect Immun. 2003; 71(9):5231-7. PMC: 187356. DOI: 10.1128/IAI.71.9.5231-5237.2003. View

2.
Lewinsohn D, Gennaro M, Scholvinck L, Lewinsohn D . Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis. 2004; 8(5):658-74. View

3.
Landis J, Koch G . The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-74. View

4.
Villarino M, Burman W, Wang Y, Lundergan L, Catanzaro A, Bock N . Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA. 1999; 281(2):169-71. DOI: 10.1001/jama.281.2.169. View

5.
Malhotra I, Mungai P, Wamachi A, Kioko J, Ouma J, Kazura J . Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol. 1999; 162(11):6843-8. View